Acadian Asset Management’s Harvard Bioscience HBIO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$459K Sell
1,039,225
-37,844
-4% -$16.7K ﹤0.01% 1158
2025
Q1
$606K Buy
1,077,069
+78,276
+8% +$44K ﹤0.01% 1047
2024
Q4
$2.1M Buy
998,793
+125,179
+14% +$264K 0.01% 753
2024
Q3
$2.35M Sell
873,614
-89,492
-9% -$240K 0.01% 701
2024
Q2
$2.74M Sell
963,106
-40,991
-4% -$117K 0.01% 677
2024
Q1
$4.26M Sell
1,004,097
-5,753
-0.6% -$24.4K 0.01% 512
2023
Q4
$5.4M Sell
1,009,850
-54,007
-5% -$289K 0.02% 428
2023
Q3
$4.57M Sell
1,063,857
-41,396
-4% -$178K 0.02% 461
2023
Q2
$6.07M Hold
1,105,253
0.02% 402
2023
Q1
$4.64M Hold
1,105,253
0.02% 473
2022
Q4
$3.06M Buy
1,105,253
+26,874
+2% +$74.4K 0.02% 566
2022
Q3
$2.76M Buy
1,078,379
+29,550
+3% +$75.6K 0.02% 544
2022
Q2
$3.78M Sell
1,048,829
-18,485
-2% -$66.6K 0.02% 480
2022
Q1
$6.63M Sell
1,067,314
-70,594
-6% -$438K 0.03% 400
2021
Q4
$8.02M Sell
1,137,908
-5,422
-0.5% -$38.2K 0.03% 351
2021
Q3
$7.98M Buy
1,143,330
+67,673
+6% +$472K 0.03% 351
2021
Q2
$8.96M Buy
1,075,657
+55,792
+5% +$465K 0.03% 334
2021
Q1
$5.57M Sell
1,019,865
-76,777
-7% -$419K 0.02% 446
2020
Q4
$4.7M Buy
1,096,642
+6,804
+0.6% +$29.2K 0.02% 513
2020
Q3
$3.28M Sell
1,089,838
-11,539
-1% -$34.7K 0.01% 528
2020
Q2
$3.41M Buy
1,101,377
+29,415
+3% +$91.2K 0.01% 571
2020
Q1
$2.37M Buy
1,071,962
+11,493
+1% +$25.4K 0.01% 552
2019
Q4
$3.23M Sell
1,060,469
-21,303
-2% -$64.9K 0.01% 548
2019
Q3
$3.33M Buy
1,081,772
+29,744
+3% +$91.5K 0.01% 550
2019
Q2
$2.1M Buy
1,052,028
+281,293
+36% +$562K 0.01% 610
2019
Q1
$3.32M Sell
770,735
-38,214
-5% -$165K 0.01% 547
2018
Q4
$2.57M Sell
808,949
-45,650
-5% -$145K 0.01% 518
2018
Q3
$4.48M Buy
854,599
+1,703
+0.2% +$8.94K 0.02% 399
2018
Q2
$4.56M Buy
852,896
+4,882
+0.6% +$26.1K 0.02% 404
2018
Q1
$4.24M Buy
848,014
+141,470
+20% +$708K 0.02% 435
2017
Q4
$2.33M Sell
706,544
-3,211
-0.5% -$10.6K 0.01% 527
2017
Q3
$2.67M Sell
709,755
-25,814
-4% -$97K 0.01% 499
2017
Q2
$1.88M Sell
735,569
-3,162
-0.4% -$8.06K 0.01% 583
2017
Q1
$1.92M Sell
738,731
-23,004
-3% -$59.9K 0.01% 629
2016
Q4
$2.32M Hold
761,735
0.01% 561
2016
Q3
$2.07M Buy
761,735
+31,956
+4% +$86.9K 0.01% 531
2016
Q2
$2.09M Buy
729,779
+21,961
+3% +$62.8K 0.01% 513
2016
Q1
$2.14M Buy
707,818
+15,028
+2% +$45.4K 0.01% 528
2015
Q4
$2.41M Sell
692,790
-20,966
-3% -$72.8K 0.01% 544
2015
Q3
$2.7M Sell
713,756
-165,197
-19% -$624K 0.01% 497
2015
Q2
$5.01M Sell
878,953
-1,976
-0.2% -$11.3K 0.02% 408
2015
Q1
$5.13M Buy
880,929
+9,100
+1% +$53K 0.02% 391
2014
Q4
$4.95M Hold
871,829
0.02% 404
2014
Q3
$3.56M Buy
871,829
+402,874
+86% +$1.65M 0.02% 411
2014
Q2
$2.14M Buy
468,955
+360,882
+334% +$1.64M 0.01% 489
2014
Q1
$512K Buy
108,073
+18,593
+21% +$88.1K ﹤0.01% 668
2013
Q4
$421K Sell
89,480
-52,448
-37% -$247K ﹤0.01% 717
2013
Q3
$566K Sell
141,928
-123,717
-47% -$493K ﹤0.01% 614
2013
Q2
$947K Buy
+265,645
New +$947K 0.01% 497